Tiny typos spark TGA product alert

Posted 8 April 2025 PM

Two tiny typographical errors spotted on the packaging of Takeda's ADHD medication Vyvanse have sparked a social media frenzy, resulting in a rise in adverse event reports to the TGA and claims of decreased efficacy.

A product alert has been issued for Vyvanse capsules of multiple strengths. The problem is the addition of the letter "s" to the word capsule so the packaging states: "Each capsules contain..." instead of "Each capsule contains..."

To see the whole article, please login